OXAVER 100 tabs x 10mg Oxandrolone

Comprehensive Clinical and Pharmacological Guide to Oxaver (Oxandrolone 10mg Tablets)

1. Overview of Oxaver and Active Compound Chemistry

Oxaver represents a pharmaceutical formulation containing Oxandrolone at a concentration of 10mg per tablet, with a total package count of 100 tablets. Structurally known as 17β-hydroxy-17α-methyl-2-oxa-5α-androstan-3-one, Oxandrolone is an oral anabolic-androgenic steroid (AAS) derived from dihydrotestosterone (DHT). The molecular architecture is distinctive: the carbon-2 atom in the A-ring is replaced with an oxygen atom, and a methyl group is incorporated at the C17-alpha position.

This chemical reconfiguration yields two distinct functional attributes. First, substituting carbon with oxygen drastically enhances the compound's anabolic potency while dampening its relative androgenic activity. Second, the 17α-alkylation allows the tablet to survive first-pass hepatic metabolism, ensuring high oral bioavailability. Consequently, Oxaver exhibits a high anabolic-to-androgenic ratio, making it an object of study in tissue preservation, catabolic state reversal, and recovery therapeutics.

2. Cellular Mechanism of Action and Metabolic Dynamics

Oxandrolone exerts its biological influence primarily by binding directly to intracellular androgen receptors present in skeletal muscle, bone, and neural tissues. Upon binding, the receptor-ligand complex translocates into the cell nucleus, altering gene transcription to upregulate protein synthesis and enhance intracellular nitrogen retention. Nitrogen retention is a critical marker for anabolic status, as a positive nitrogen balance prevents muscle breakdown during periods of caloric restriction, severe physical trauma, or metabolic stress.

A major feature of Oxandrolone is its complete resistance to the aromatase enzyme. Because it cannot convert into estrogen, treatment with Oxaver does not precipitate estrogenic complications such as systemic water retention, subcutaneous fluid accumulation, or gynecomastia. Furthermore, Oxandrolone exhibits minimal interaction with 5α-reductase, meaning it does not convert into a more potent androgenic metabolite in target tissues like the skin or prostate, keeping its androgenic activity relatively stable across systemic tissues.

3. Approved Clinical Indications and Medical Context

In professional medical practice, Oxandrolone is prescribed under strict supervisory protocols to treat conditions characterized by significant tissue wasting, structural weakness, or impaired recovery mechanisms:

• Weight Regain Following Severe Trauma or Surgery: Used as adjunctive therapy to restore body weight lost after extensive surgical operations, chronic infections, severe physical trauma, or extensive thermal burns.
• Mitigation of Corticosteroid-Induced Catabolism: Administered to offset protein catabolism and muscle atrophy in patients undergoing prolonged, high-dose corticosteroid treatment.
• Relief of Osteoporosis-Related Bone Pain: Utilized to decrease bone pain and support bone mineral density in patients diagnosed with advanced osteoporosis.
• Pediatric Constitutional Growth Delay: Historicall